Researchers identify the origin of a deadly brain cancer

Researchers at McGill University are hopeful that the identification of the origin and a specific gene needed for tumour growth could lead to new therapeutics to treat a deadly brain cancer that arises in teens and young adults. The discovery relates to a subgroup of glioblastoma, a rare but aggressive form of cancer that typically proves fatal within three years of onset.

Pfizer Canada donation will help new researchers change the future

MONTREAL, QUEBEC – Pfizer Canada has made a $600,000 gift to the McGill Interdisciplinary Initiative in Infection and Immunity (MI4) via McGill University and the McGill University Health Centre (MUHC) Foundation. The gift, which was announced today during the 2nd annual MI4 Scientific Symposium, will support innovation and life-changing research through the creation of the Pfizer Early Career Investigator Awards.

Transforming coronavirus proteins into nanoparticles may hold the key to an effective COVID-19 vaccine

Changing makeup of a specific protein has the potential to neutralize the virus

McGill researchers part of international team awarded NIH grant to study causes and predictors of emerging psychosis

Researchers at McGill University are part of a major international study to better understand the cause and effect of psychosis in adolescents and young adults who are at risk for this condition. The research, which is being led by the Department of Psychiatry at Yale University, will be funded by a $52 million grant from the National Institutes of Health (NIH).

First genetic sequencing of COVID in Quebec shows roots of outbreak

Initial results of study show that an estimated 250 independent events following spring break travel in March led to 60,000 people being infected

$12.5 million awarded to Montreal team to study Parkinson’s Disease

A group of scientists at University of Montreal, The Neuro (Montreal Neurological Institute-Hospital), and McGill University has been awarded a major research grant of over $12.5 million from the Aligning Science Across Parkinson’s (ASAP) initiative over the next three years to study Parkinson’s disease. ASAP’s implementation partner The Michael J Fox Foundation for Parkinson’s Research issued the grant.

Molecular alterations in neuronal trophic regulation in Alzheimer’s pathology begin decades before detectable cognitive impairments

Findings could lead to development of pre-clinical stage therapeutics

By Jason Clement

Game-changing blood test accurately detects Alzheimer’s disease

McGill-Gothenburg collaboration yields affordable test that could revolutionize the way AD is diagnosed, studied and treated

By Gillian Woodford

Getting off of the blood sugar roller coaster

McGill researchers are pioneering a new artificial pancreas system that provides life-changing support to people living with type 1 diabetes.  

By Ashley Rabinovitch

Vitamin E effective, safe for fatty liver in HIV patients

By Gillian Woodford

A type of fatty liver disease that commonly affects patients with HIV can be safely treated with vitamin E, a McGill-led study has found.

Nonalcoholic steatohepatitis (NASH) is a severe form of nonalcoholic fatty liver disease (NAFLD) and is characterized by liver inflammation and cell damage. It is a potentially dangerous condition that can progress to cirrhosis or liver cancer.